Background and activities

Dr. Siver A. Moestue earned his PhD at the Norwegian University of Science and Technology (NTNU). He is currently a postdoctoral research fellow at the MR Centre, NTNU, on a personal research grant from the Norwegian Cancer Society.  Trained a MSc. Pharm at the University of Oslo, he started his career as a preclinical researcher in GE Healthcare. Here, he was involved in development of molecularly targeted contrast agents for SPECT/PET, and development of the Sonazoid® microbubble.  In his current research, Dr. Moestue is investigating the use of MRI and MRS in cancer therapy monitoring, with special focus on metabolic biomarkers.

Scientific, academic and artistic work

Displaying a selection of activities. See all publications in the database

Journal publications


  • Grinde, Maria Tunset; Moestue, Siver Andreas; Eldrid, Borgan; Risa, Øystein; Engebraaten, Olav; Gribbestad, Ingrid S. (2010) 13C HR MAS MRS reveals differences in the glucose metabolism between two breast cancer xenograft models with different gene expression pattern. International Society of Magnetic Resonance in Medicine (ISMRM) . ISMRM; Stockholm. 2010-05-01 - 2010-05-07.

Postal address

Department of Circulation and Medical Imaging Norwegian University of Science and Technology Postboks 8905 7491 Trondheim Norway